Researchers at Ben-Gurion University of the Negev are on the verge of a breakthrough that is bringing the world closer to finding a cure for diabetes. They’re discovering ways to create minimally invasive treatment options that will have a profound impact on the daily lives of diabetics and their families.
Diabetes is a disease that has a global impact and leaves many patients without effective tools to manage the disease. A team of BGU researchers, led by Dr. Eli Lewis, has developed a new therapy that may provide a cure. more »
BGU's Dr. Eli Lewis grafted healthy insulin producing islet cells into diabetic mice and then added an anti-inflammatory drug called alpha-1-antitrypsin, or AAT. Within three months, the AAT created successful survival for the grafted islet cells and the mice started making insulin like any normal healthy pancreas. more »
BGU researchers are working on ways not only to diagnose and manage diabetes, but also to cure it.
Dr. Eli Lewis, who heads BGU’s Clinical Islet Laboratory, is pursuing three major goals: transplants and new drugs, gene therapy, and the creation of a new “transgenic” mouse that can tolerate human material for inflammation drug experimentation.
Prof. Angel Porgador, a member of BGU’s National Institute for Biotechnology in the Negev, is investigating whether reducing the function of the immune system’s natural killer (NK cells) can delay the development of type 1 diabetes and the need for a large amount of insulin.
AABGU is raising funds to support BGU’s innovative diabetes research. Be a part of it.
Donate any amount to help BGU find a life-changing cure for diabetes.